SCHEMBL25399206

SCHEMBL25399206

CC(C)C[C@H](NC(=O)C1CC(c2cccc(Oc3ccccc3)c2)=NO1)B(O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.58
▸ TSHR P16473 7/20 0.56
▸ CYP2C19 P33261 5/20 0.56
▸ CYP3A4 P08684 4/20 0.56
▸ LMNA P02545 4/20 0.56
▸ CYP1A2 P05177 4/20 0.56
▸ CYP2D6 P10635 2/20 0.56
▸ ALDH1A1 P00352 6/20 0.52
▸ GAA P10253 3/20 0.52
▸ MAPK10 P53779 6/20 0.48
▸ HPGD P15428 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25399210 1.00 NPSR1 (0.58) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25401129 0.92 POLB (0.56) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25401125 0.92 POLB (0.56) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25400683 0.90 NPSR1 (0.54) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25400691 0.90 NPSR1 (0.54) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25399613 0.90 NPSR1 (0.53) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25399609 0.90 NPSR1 (0.53) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25399140 0.88 CA1 (0.57) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25399144 0.88 CA1 (0.57) NPSR1TSHRCYP2C19CYP3A4LMNA
SCHEMBL25401694 0.86 CA1 (0.55) NPSR1TSHRCYP2C19LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 — — US disclosed
US-20240101579-A1 BORONIC ACID COMPOUNDS LG CHEM, LTD. (KR) 2024-03-28 — — US disclosed
EP-4242213-A1 BORONIC ACID COMPOUND Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed
CN-116568310-A Boric acid compounds 株式会社LG化学 2023-08-08 — — CN disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570675-B2 Boronic acid compounds PSMB6, PSMB3, PSMB2 NPSR1 2598/4885TSHR 1670/4885CYP2C19 2008/4885
US-20240101579-A1 BORONIC ACID COMPOUNDS PSMB11, PSMB1, BACH1 NPSR1 4263/4885TSHR 4034/4885CYP2C19 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback